You are here

Home

Rimedion, Inc.

Company Information
Address
351 W. 10th Street Suite 514
Indianapolis, IN 46202
United States


http://www.rimedion.com
Information

UEI: CD88LM1CK1A6

# of Employees: 2
Ownership Information

HUBZone Owned: No

Socially and Economically Disadvantaged: No

Woman Owned: No

Award Charts




Award Listing

  • Record 1 TO 3

  1. Lentiviral Vector for the treatment of Fanconi Anemia

    Amount: $1,278,659.00

    DESCRIPTIONprovided by applicantIn this Phase II STTR application Rimedion seeks to commercialize a novel treatment for patients suffering from Fanconi anemia and request funding for a Phase I II clin ...

    STTRPhase II2015Department of Health and Human Services National Institutes of Health

  2. Lentiviral Vectors for the Treatment of Fanconi Anemia

    Amount: $223,172.00

    DESCRIPTION (provided by applicant): HIV-1 based lentiviral vectors are becoming an increasingly attractive means of integrating transgenes into target cells. Vectors are in or enterning clinical tria ...

    STTRPhase I2010Department of Health and Human Services National Institutes of Health

  3. Packaging Cell Lines for Lentiviral Vector Products

    Amount: $198,889.00

    DESCRIPTION (provided by applicant): HIV-1 based lentiviral vectors are becoming an increasingly attractive means of integrating transgenes into target cells. Vectors are in or enterning clinical tria ...

    STTRPhase I2010Department of Health and Human Services National Institutes of Health
US Flag An Official Website of the United States Government